Intra‐Renal Delivery of Progenitor Cells Improves Systemic Inflammation, Oxidative Stress, and Myocardial Microvascular Function in Experimental Renovascular Disease
Renovascular disease (RVD) and hypertension (HT) are cardiovascular risk factors, but if recovery of renal function can reverse cardiac dysfunction remained unclear. We hypothesized that improved stenotic kidney function would rescue myocardial microvascular (MMV) function in renovascular HT by reducing oxidative stress and inflammation. Single‐kidney hemodynamics and function and MMV permeability were assessed in pigs in vivo using CT after 6 weeks of RVD. Autologous endothelial progenitor cells (EPC) were then infused intra‐renally, and studies repeated 4 weeks later (RVD+EPC, n=7). Normal and untreated RVD (n=7 each) served as controls. Blood pressure was similarly increased in RVD and RVD+EPC pigs. Compared to normal, RVD showed elevated systemic TNF‐alpha (142.3± 3.7 vs 43.3 ± 3.5 pg/ml, p<0.001) and oxidized‐LDL, blunted glomerular filtration rate (47.9±10.1 vs 70.8 ± 4.3 ml/min, p<0.05), decreased MMV volume fraction, increased MMV permeability, and myocardial fibrosis. EPC were rarely observed in myocardium. However, RVD+EPC showed a decrease in TNF‐alpha (90.5± 2.9, p<0.01 vs RVD) and oxidized‐LDL, implying decreased inflammation and oxidative stress. Furthermore, not only renal, but also MMV function were significantly improved in RVD+EPC. In conclusion, selective improvement in renal function reduces oxidative stress and inflammation and preserves remote MMV function, underscoring functionally important cardiorenal crosstalk.
Early experimental hypertension preserves the myocardial microvasculature but aggravates cardiac injury distal to chronic coronary artery obstruction
Coronary artery disease is a leading cause of death. Hypertension (HT) increases the incidence of cardiac events, but its effect on cardiac adaptation to coexisting coronary artery stenosis (CAS) is unclear. We hypothesized that concurrent HT modulates microvascular function in chronic CAS and aggravates microvascular remodeling and myocardial injury. Four groups of pigs ( n = 6 each) were studied: normal, CAS, HT, and CAS+HT. CAS and HT were induced by placing local irritant coils in the left circumflex coronary artery and renal artery, respectively. Six weeks later multidetector computerized tomography (CT) was used to assess systolic and diastolic function, microvascular permeability, myocardial perfusion, and responses to adenosine in the “area at risk.” Microvascular architecture, inflammation, and fibrosis were then explored in cardiac tissue. Basal myocardial perfusion was similarly decreased in CAS and CAS+HT, but its response to adenosine was significantly more attenuated in CAS. Microvascular permeability in CAS+HT was greater than in CAS and was accompanied by amplified myocardial inflammation, fibrosis, and microvascular remodeling, as well as cardiac systolic and diastolic dysfunction. On the other hand, compared with normal, micro-CT-derived microvascular (20–200 μm) transmural density decreased in CAS but not in HT or CAS+HT. We conclude that the coexistence of early renovascular HT exacerbated myocardial fibrosis and vascular remodeling distal to CAS. These changes were not mediated by loss of myocardial microvessels, which were relatively preserved, but possibly by exacerbated myocardial inflammation and fibrosis. HT modulates cardiac adaptive responses to CAS and bears cardiac functional consequences.